Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Conference News AHA 2025

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

Michael O'Riordan

November 11, 2025

News Industry News

CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019

September 25, 2019

News Daily News

Abciximab in ‘Short Supply’ Worldwide

Shelley Wood

April 13, 2018

News Daily News

New Performance and Quality Metrics for STEMI and NSTEMI Care

Michael O'Riordan

September 21, 2017

News Daily News

Viper Peptides Explored Anew as Antiplatelet Drugs

Yael L. Maxwell

June 08, 2017

News Conference News ESC 2016

DOCTORS: Optical Coherence Tomography Improves Stent Placement, Ups FFR in NSTE ACS

Shelley Wood

August 30, 2016

News Daily News

冠脉内阿昔单抗显示对糖尿病 STEMI 患者有优势

L.A. McKeown

August 11, 2016

News Daily News

Intracoronary Abciximab Shows Advantage in Diabetic STEMI Patients

L.A. McKeown

August 11, 2016

News Daily News

El Abciximab Intracoronario es Beneficioso en Pacientes Diabéticos Víctimas de STEMI

L.A. McKeown

August 11, 2016

Presentation

Intracoronary Abciximab Shows Advantage in Diabetic STEMI Patients

Presenter: Raffaele Piccolo

August 10, 2016

News Conference News ESC 2013

Cooling, PCI Improves Long-term Outcomes for Cardiac Arrest Survivors

Yael L. Maxwell

September 04, 2013

News Daily News

Meta-Analysis: Increased MI Risk with Double Bifurcation Stenting Due in Part to Stent Thrombosis

July 24, 2013

News Daily News

Meta-análisis: Aumento del riesgo de IM con la colocación de stent doble en la bifurcación se debe en parte a la trombosis del stent

July 24, 2013

News Daily News

Una Prueba Temprana de Esfuerzo Físico tras una PCI Primaria resulta Simple, Segura y Económica

May 10, 2012

News Daily News

Early Exercise Stress Testing After Primary PCI Simple, Safe, Economical

May 10, 2012

Presentation

MISTRAL: Abciximab Prehospitalario contra STEMI

Presenter: Patrick Ohlmann

February 09, 2012

Advertisement

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019

Abciximab in ‘Short Supply’ Worldwide

New Performance and Quality Metrics for STEMI and NSTEMI Care

Viper Peptides Explored Anew as Antiplatelet Drugs

DOCTORS: Optical Coherence Tomography Improves Stent Placement, Ups FFR in NSTE ACS

冠脉内阿昔单抗显示对糖尿病 STEMI 患者有优势

Intracoronary Abciximab Shows Advantage in Diabetic STEMI Patients

El Abciximab Intracoronario es Beneficioso en Pacientes Diabéticos Víctimas de STEMI

Intracoronary Abciximab Shows Advantage in Diabetic STEMI Patients

Cooling, PCI Improves Long-term Outcomes for Cardiac Arrest Survivors

Meta-Analysis: Increased MI Risk with Double Bifurcation Stenting Due in Part to Stent Thrombosis

Meta-análisis: Aumento del riesgo de IM con la colocación de stent doble en la bifurcación se debe en parte a la trombosis del stent

Una Prueba Temprana de Esfuerzo Físico tras una PCI Primaria resulta Simple, Segura y Económica

Early Exercise Stress Testing After Primary PCI Simple, Safe, Economical

MISTRAL: Abciximab Prehospitalario contra STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content